首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Modeling the Effect of Composition on Formation of Aerosolized Nanoemulsion System Encapsulating Docetaxel and Curcumin Using D-Optimal Mixture Experimental Design
【2h】

Modeling the Effect of Composition on Formation of Aerosolized Nanoemulsion System Encapsulating Docetaxel and Curcumin Using D-Optimal Mixture Experimental Design

机译:用D-最优混合物实验设计模拟组合物对雾化纳米乳剂系统形成的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The synergistic anticancer effect of docetaxel (DTX) and curcumin (CCM) has emerged as an attractive therapeutic candidate for lung cancer treatment. However, the lack of optimal bioavailability because of high toxicity, low stability, and poor solubility has limited their clinical success. Given this, an aerosolized nanoemulsion system for pulmonary delivery is recommended to mitigate these drawbacks. In this study, DTX- and CCM-loaded nanoemulsions were optimized using the D-optimal mixture experimental design (MED). The effect of nanoemulsion compositions towards two response variables, namely, particle size and aerosol size, was studied. The optimized formulations for both DTX- and CCM-loaded nanoemulsions were determined, and their physicochemical and aerodynamic properties were evaluated as well. The MED models achieved the optimum formulation for DTX- and CCM-loaded nanoemulsions containing a 6.0 wt% mixture of palm kernel oil ester (PKOE) and safflower seed oils (1:1), 2.5 wt% of lecithin, 2.0 wt% mixture of Tween 85 and Span 85 (9:1), and 2.5 wt% of glycerol in the aqueous phase. The actual values of the optimized formulations were in line with the predicted values obtained from the MED, and they exhibited desirable attributes of physicochemical and aerodynamic properties for inhalation therapy. Thus, the optimized formulations have potential use as a drug delivery system for a pulmonary application.
机译:多西紫杉醇(DTX)和姜黄素(CCM)的协同抗癌效应已成为肺癌治疗有吸引力的治疗候选者。然而,由于毒性高,稳定性低,溶解度较低,缺乏最佳的生物利用度,其临床成功有限。鉴于这一点,建议使用肺部递送的雾化纳米乳液系统来减轻这些缺点。在该研究中,使用D-最佳混合物实验设计(MED)优化了DTX和CCM负载纳米乳液。研究了纳米乳液组合物朝向两个反应变量,即粒度和气溶胶尺寸的影响。确定了DTX和CCM加载纳米乳液的优化制剂,并评估了它们的物理化学和空气动力学性质。 MED模型达到含有6.0wt%棕榈仁油酯(PKOE)和红花种子油(1:1),卵磷脂的2.5%(1:1),2.0wt%的混合物的6.0wt%的纳米乳液的最佳制剂在水相中吐温85和跨度85(9:1)和2.5wt%的甘油。优化制剂的实际值与从MED获得的预测值符合,并且它们表现出用于吸入治疗的物理化学和空气动力学性质的理想属性。因此,优化的制剂具有作为肺应用的药物递送系统的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号